John Lin is an Internal Medicine physician and VA Health Services Research and Development Fellow. His research interests include evaluating the value of novel and high-cost therapeutics, risk-adjustment modeling, and end-of-life care in chronic disease.

John received an AB from Harvard University (2008) in Economics and Healthcare Policy, an MD from Baylor College of Medicine (2014), and completed his Internal Medicine residency at the University of California San Francisco (2017).

Professional Education

  • Doctor of Medicine, Baylor College Of Medicine (2014)
  • Bachelor of Arts, Harvard University (2008)


All Publications

  • The Cost-Effectiveness of Initial vs Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors in the United States Barnes, J. I., Lin, J., Owens, D. K., Goldhaber-Fiebert, J., Kunz, P. L. LIPPINCOTT WILLIAMS & WILKINS. 2019: 429
  • Cost-Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia Journal of Clinical Oncology Lin, J., Lerman, B. J., Barnes, J., Boursiquot, B., Tan, Y., Robinson, A., Davis, K., Owens, D., Goldhaber-Fiebert, J. 2018

    View details for DOI 10.1200/JCO.2018.79.0642